KKR-backed JB Chemicals bets big on lozenges and probiotic products

JB Chemicals now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.

KKR-backed JB Chemicals, the owner of marquee brands Rantac and Metrogyl, is trying to make a mark in the lozenges category in a bid to increase its share in the domestic market to 60 per cent of turnover.

Besides, the Mumbai-headquartered company is trying to expand the Sanzyme portfolio of probiotic products.

At present, JB Chemicals is only contract manufacturing for multinational clients such as J&J, P&G, etc. The company, which launched its own lozenges this year, now plan to enter new areas like sleep disorders, sexual wellness, motion sickness, and immunity apart, from the conventional areas like cough, sore throat, etc.

“We